Chigusa Nakahashi-Oda

6PUBLICATIONS
12CO-AUTHORS
AllergyHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyNeural engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 12, 2025
Inhibitory immunoreceptors CD300a and CD300lf cooperate to regulate mast cell activation.

Hanbin Lee, Chigusa Nakahashi-Oda, Wenxin Lyu

|Jan 13, 2025
A Humanized Monoclonal Antibody Against CD300A Ameliorates Acute Ischemic Stroke in Humanized Mice.

Fumie Abe, Chigusa Nakahashi-Oda, Hanbin Lee

|Oct 30, 2023
Development of Monoclonal Antibodies Specific to Either CD300AR111 or CD300AQ111 or Both.

Hitoshi Koizumi, Chigusa Nakahashi-Oda, Wenxin Lyu

|Oct 15, 2021
CD300a blockade enhances efferocytosis by infiltrating myeloid cells and ameliorates neuronal deficit after ischemic stroke.

Chigusa Nakahashi-Oda, Satoshi Fujiyama, Yuta Nakazawa

|Nov 24, 2019
Cutting Edge: Involvement of the Immunoreceptor CD300c2 on Alveolar Macrophages in Bleomycin-Induced Lung Fibrosis.

Yuta Nakazawa, Shigeo Ohtsuka, Chigusa Nakahashi-Oda

Pageof 1